StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TERAI.BO$107.05-4.38%
Fair $107.05+0.0%

TERAI.BO

Terai Tea Company Limited

Consumer Defensive / Farm ProductsBSE

$107.05

-4.90 (-4.38%)

Fairly Valued+0.0%Fair Value $107.05Fund rank 29/100 · Data gapFallback financials|
SA 53/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $6.1M · quality 49.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 30/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

53/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · TERAI.BOLocal privado en este navegador · Terai Tea Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$736M

P/E

7.7x

↓

EV/EBITDA

9.9x

↑

ROE

5.9%

↓

Gross Margin

15.8%

↓

Debt/Equity

0.42

↑
52-Week Range$107
$83$201

TradingView lightweight chart

TERAI.BO price, volumen y niveles de valoración

Último $107.05Periodo +7.6%
Fair value: $107.05

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.1%

FCF CAGR

-8.8%

FCF margin

17.3%

FCF / Net income

1.87x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.03B · net income $95.3M · FCF $178.1M

2022-FY → 2025-FY

Gross margin

15.8%-1.5% pts

Operating margin

-1.5%+4.3% pts

Net margin

9.3%-3.6% pts

FCF margin

17.3%-14.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.03B$1.03B$1.08B$931.6M$731.8M
Net Income$95.3M$95.3M$49.3M$13.1M$94.0M
EBITDA$90.9M$90.9M$68.4M$52.4M$124.9M
EPS13.8613.867.161.9015.82
Gross Margin15.8%15.8%14.2%19.4%17.3%
Operating Margin-1.5%-1.5%-1.9%-1.1%-5.8%
Net Margin9.3%9.3%4.6%1.4%12.8%
Balance Sheet
Debt/Equity0.420.420.210.250.22
Cash Flow
Free Cash Flow$178.1M$178.1M$6.1M$-88.7M$234.8M
Returns
ROE5.9%5.9%3.3%0.9%6.5%
Valuation
P/E7.727.7212.4636.174.70
EV/EBITDA9.929.9213.5315.726.56
P/B0.460.460.410.320.35
Growth & Yield
Revenue Growth-4.7%-4.7%16.0%27.3%—
EPS Growth93.6%93.6%277.0%-88.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-11.8%

fácil

EPS terminal req.

$9.50

Spread vs growth

105.4%

5Y implied EPS CAGR

-3.7%

fácil

EPS terminal req.

$11.49

Spread vs growth

97.3%

10Y implied EPS CAGR

2.9%

fácil

EPS terminal req.

$18.51

Spread vs growth

90.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -43.7%

Total return

-43.7%

Start / end P/E

26.6x → 7.7x

EPS bridge

7.16 → 13.86

Residual

-66.4%

EPS growth+93.6%
Multiple rerating-70.9%
Dividend+0.0%
Residual / FX / buybacks / cross-term-66.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.